25 May 2013
Keywords: adams, resp, gets, not-approvable, letter, mucinex, codeine
Article | 05 November 2007
The US Food and Drug Administration has issued an "approvable letter" on New Jersey-based Adams Respiratory Therapeutics' New Drug Application ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.